Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

COVID-19 patients undergoing TAVR may face a higher risk of death

The study included data from more than 3,000 TAVR patients who received care from January 2020 to January 2021. 

M&A mergers and acquisitions business deal

Endologix acquires medical device company focused on peripheral artery disease

PQ Bypass, the company Endologix acquired, has gained significant attention for its Detour platform, an investigational treatment for percutaneous femoral-popliteal bypass.

Thumbnail

New research highlights the close connection between diabetes and cardiovascular issues

Chronic coronary syndromes can more than triple a person's chances of developing diabetes, researchers found. 

Thumbnail

Specialists complete first procedure in historic head-to-head TAVR study

The global trial is designed to compare TAVR systems from Medtronic and Edwards Lifesciences when treating patients with small annuli.

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 

Thumbnail

How early marijuana use affects the heart later in life

Researchers used ultrasound imaging to examine the hearts of young adults who smoked marijuana and those who did not. Their full analysis was published in the Journal of Applied Physiology

Thumbnail

New research points to a better strategy for cardiovascular risk assessment

The team sees significant potential in its findings, though they still hope to make the technique "simpler and more clinically implementable."

Johnson & Johnson COVID-19 vaccine being investigated for possible blood clot risk

The European Medicines Agency is investigating the issue with help from the FDA. At this stage, the group emphasized that it remains unclear if the Johnson & Johnson vaccine is associated with any specific blood clot risk.